apoprotein , lipoprotein and lipid parameters of 36 normolipidemic subjects ( 23 males , mean age 22.7 +/- 7.6 years ; 13 females , mean age 26.2 +/- 9.8 years ) receiving oral isotretinoin ( mean daily dose 0.73 +/- 0.26 mg/kg body weight ) for nodulocystic acne ( n = 18 ) , severe acne papulopustulosa ( n = 15 ) , gram-negative folliculitis ( n = 2 ) and papulopustular rosacea ( n = 1 ) were monitored before and during isotretinoin therapy at biweekly intervals over a period of 14.6 +/- 5.6 weeks .
C0001144
acne
C0022265
isotretinoin